Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report

Abstract Background Anti-mGluR1 encephalitis is a form of autoimmune encephalitis, with limited reports globally and only two cases reported from Japan. There are uncertainties regarding the optimal immunosuppressive agents and individual drug responses. Herein, we report a case of anti-mGluR1 encep...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Kazuki Yamada, Hiroaki Yaguchi, Shuntaro Nakamura, Kazuhiro Horiuchi, Shintaro Fujii, Taichi Nomura, Akihiko Kudo, Akira Takekoshi, Nobuaki Yoshikura, Akio Kimura, Takayoshi Shimohata, Ichiro Yabe
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-08-01
Serija:	BMC Neurology
Teme:	Anti-mGluR1 encephalitis Cerebellar blood flow MGluR1 antibody Rituximab
Online dostop:	https://doi.org/10.1186/s12883-025-04345-8
Oznake:	Označite Brez oznak, prvi označite!